264 related articles for article (PubMed ID: 20967875)
1. Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.
Chen W; Cormode DP; Fayad ZA; Mulder WJM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):146-161. PubMed ID: 20967875
[TBL] [Abstract][Full Text] [Related]
2. Liposomes loaded with hydrophilic magnetite nanoparticles: Preparation and application as contrast agents for magnetic resonance imaging.
German SV; Navolokin NA; Kuznetsova NR; Zuev VV; Inozemtseva OA; Anis'kov AA; Volkova EK; Bucharskaya AB; Maslyakova GN; Fakhrullin RF; Terentyuk GS; Vodovozova EL; Gorin DA
Colloids Surf B Biointerfaces; 2015 Nov; 135():109-115. PubMed ID: 26241922
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular molecular imaging: an overview.
Saraste A; Nekolla SG; Schwaiger M
Cardiovasc Res; 2009 Sep; 83(4):643-52. PubMed ID: 19553359
[TBL] [Abstract][Full Text] [Related]
4. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in magnetoliposome for heart drug delivery.
Namdari M; Cheraghi M; Negahdari B; Eatemadi A; Daraee H
Artif Cells Nanomed Biotechnol; 2017 Sep; 45(6):1-7. PubMed ID: 28272903
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Magnetic Nanoparticle-based Molecular Probes for Hepatocellular Carcinoma Diagnosis and Therapy.
Zhang Q; Wang S; Qiao R; Whittaker MR; Quinn JF; Davis TP; Li H
Curr Pharm Des; 2018; 24(21):2432-2437. PubMed ID: 29788872
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance nanoparticles for cardiovascular molecular imaging and therapy.
Cyrus T; Winter PM; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):705-15. PubMed ID: 16076280
[TBL] [Abstract][Full Text] [Related]
8. Enhanced magnetic resonance contrast of Fe₃O₄ nanoparticles trapped in a porous silicon nanoparticle host.
Kinsella JM; Ananda S; Andrew JS; Grondek JF; Chien MP; Scadeng M; Gianneschi NC; Ruoslahti E; Sailor MJ
Adv Mater; 2011 Sep; 23(36):H248-53. PubMed ID: 21842475
[No Abstract] [Full Text] [Related]
9. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system.
Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ
Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437
[TBL] [Abstract][Full Text] [Related]
10. An update on clinical applications of magnetic nanoparticles for increasing the resolution of magnetic resonance imaging.
Zeinali Sehrig F; Majidi S; Asvadi S; Hsanzadeh A; Rasta SH; Emamverdy M; Akbarzadeh J; Jahangiri S; Farahkhiz S; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1583-8. PubMed ID: 26584684
[TBL] [Abstract][Full Text] [Related]
11. MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery.
Lorenzato C; Cernicanu A; Meyre ME; Germain M; Pottier A; Levy L; de Senneville BD; Bos C; Moonen C; Smirnov P
Contrast Media Mol Imaging; 2013; 8(2):185-92. PubMed ID: 23281291
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging of activated platelets via antibody-targeted ultra-small iron oxide nanoparticles displaying unique dual MRI contrast.
Ta HT; Li Z; Hagemeyer CE; Cowin G; Zhang S; Palasubramaniam J; Alt K; Wang X; Peter K; Whittaker AK
Biomaterials; 2017 Jul; 134():31-42. PubMed ID: 28453956
[TBL] [Abstract][Full Text] [Related]
13. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
[No Abstract] [Full Text] [Related]
14. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
16. Pheomelanin-coated iron oxide magnetic nanoparticles: a promising candidate for negative T2 contrast enhancement in magnetic resonance imaging.
Zottis AD; Beltrame JM; Lara LR; Costa TG; Feldhaus MJ; Pedrosa RC; Ourique F; de Campos CE; Isoppo Ede A; da Silva Miranda F; Szpoganicz B
Chem Commun (Camb); 2015 Jun; 51(56):11194-7. PubMed ID: 26073290
[TBL] [Abstract][Full Text] [Related]
17. Engineered Theranostic Magnetic Nanostructures: Role of Composition and Surface Coating on Magnetic Resonance Imaging Contrast and Thermal Activation.
Nandwana V; Ryoo SR; Kanthala S; De M; Chou SS; Prasad PV; Dravid VP
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6953-61. PubMed ID: 26936392
[TBL] [Abstract][Full Text] [Related]
18. Design of iron oxide-based nanoparticles for MRI and magnetic hyperthermia.
Blanco-Andujar C; Walter A; Cotin G; Bordeianu C; Mertz D; Felder-Flesch D; Begin-Colin S
Nanomedicine (Lond); 2016 Jul; 11(14):1889-910. PubMed ID: 27389703
[TBL] [Abstract][Full Text] [Related]
19. Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging.
Zeng L; Wu D; Zou R; Chen T; Zhang J; Wu A
Curr Med Chem; 2018; 25(25):2970-2986. PubMed ID: 28292235
[TBL] [Abstract][Full Text] [Related]
20. Improving cancer imaging with magnetic nanoparticles: where are we now?
Tietze R; Alexiou C
Nanomedicine (Lond); 2017 Feb; 12(3):167-170. PubMed ID: 28097925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
